Global PD-1 Antibody Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global PD-1 Antibody Drug market size was valued at USD 33960 million in 2022 and is forecast to a readjusted size of USD 83340 million by 2029 with a CAGR of 13.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
PD-1 is an immune checkpoint inhibitor, which is relatively widely used clinically
This report is a detailed and comprehensive analysis for global PD-1 Antibody Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global PD-1 Antibody Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global PD-1 Antibody Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global PD-1 Antibody Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global PD-1 Antibody Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for PD-1 Antibody Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global PD-1 Antibody Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Thermo Fisher, InvivoGen, BioVision Inc. and Abcam, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
PD-1 Antibody Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe PD-1 Antibody Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of PD-1 Antibody Drug, with price, sales, revenue and global market share of PD-1 Antibody Drug from 2018 to 2023.
Chapter 3, the PD-1 Antibody Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PD-1 Antibody Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and PD-1 Antibody Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of PD-1 Antibody Drug.
Chapter 14 and 15, to describe PD-1 Antibody Drug sales channel, distributors, customers, research findings and conclusion.
PD-1 is an immune checkpoint inhibitor, which is relatively widely used clinically
This report is a detailed and comprehensive analysis for global PD-1 Antibody Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global PD-1 Antibody Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global PD-1 Antibody Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global PD-1 Antibody Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global PD-1 Antibody Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for PD-1 Antibody Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global PD-1 Antibody Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Thermo Fisher, InvivoGen, BioVision Inc. and Abcam, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
PD-1 Antibody Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Pembrolizumab
- Nivolumab
- Sindilimab
- Toripalimab
- Other
- Hospital
- Clinic
- Other
- Novartis
- Thermo Fisher
- InvivoGen
- BioVision Inc.
- Abcam
- Bristol-Myers Squibb
- Merck
- Ono Pharmaceutical Co., Ltd
- Eli Lilly
- Chugai Pharmaceutical Co., Ltd
- BeiGene
- AbbVie
- TG Therapeutics, Inc
- Beijing Yiqiao Shenzhou Technology Co., Ltd.
- 3SBio
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe PD-1 Antibody Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of PD-1 Antibody Drug, with price, sales, revenue and global market share of PD-1 Antibody Drug from 2018 to 2023.
Chapter 3, the PD-1 Antibody Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PD-1 Antibody Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and PD-1 Antibody Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of PD-1 Antibody Drug.
Chapter 14 and 15, to describe PD-1 Antibody Drug sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of PD-1 Antibody Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global PD-1 Antibody Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Pembrolizumab
1.3.3 Nivolumab
1.3.4 Sindilimab
1.3.5 Toripalimab
1.3.6 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global PD-1 Antibody Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global PD-1 Antibody Drug Market Size & Forecast
1.5.1 Global PD-1 Antibody Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global PD-1 Antibody Drug Sales Quantity (2018-2029)
1.5.3 Global PD-1 Antibody Drug Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis PD-1 Antibody Drug Product and Services
2.1.4 Novartis PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments/Updates
2.2 Thermo Fisher
2.2.1 Thermo Fisher Details
2.2.2 Thermo Fisher Major Business
2.2.3 Thermo Fisher PD-1 Antibody Drug Product and Services
2.2.4 Thermo Fisher PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Thermo Fisher Recent Developments/Updates
2.3 InvivoGen
2.3.1 InvivoGen Details
2.3.2 InvivoGen Major Business
2.3.3 InvivoGen PD-1 Antibody Drug Product and Services
2.3.4 InvivoGen PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 InvivoGen Recent Developments/Updates
2.4 BioVision Inc.
2.4.1 BioVision Inc. Details
2.4.2 BioVision Inc. Major Business
2.4.3 BioVision Inc. PD-1 Antibody Drug Product and Services
2.4.4 BioVision Inc. PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BioVision Inc. Recent Developments/Updates
2.5 Abcam
2.5.1 Abcam Details
2.5.2 Abcam Major Business
2.5.3 Abcam PD-1 Antibody Drug Product and Services
2.5.4 Abcam PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Abcam Recent Developments/Updates
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business
2.6.3 Bristol-Myers Squibb PD-1 Antibody Drug Product and Services
2.6.4 Bristol-Myers Squibb PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bristol-Myers Squibb Recent Developments/Updates
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck PD-1 Antibody Drug Product and Services
2.7.4 Merck PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck Recent Developments/Updates
2.8 Ono Pharmaceutical Co., Ltd
2.8.1 Ono Pharmaceutical Co., Ltd Details
2.8.2 Ono Pharmaceutical Co., Ltd Major Business
2.8.3 Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Product and Services
2.8.4 Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Ono Pharmaceutical Co., Ltd Recent Developments/Updates
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly PD-1 Antibody Drug Product and Services
2.9.4 Eli Lilly PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Eli Lilly Recent Developments/Updates
2.10 Chugai Pharmaceutical Co., Ltd
2.10.1 Chugai Pharmaceutical Co., Ltd Details
2.10.2 Chugai Pharmaceutical Co., Ltd Major Business
2.10.3 Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Product and Services
2.10.4 Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Chugai Pharmaceutical Co., Ltd Recent Developments/Updates
2.11 BeiGene
2.11.1 BeiGene Details
2.11.2 BeiGene Major Business
2.11.3 BeiGene PD-1 Antibody Drug Product and Services
2.11.4 BeiGene PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BeiGene Recent Developments/Updates
2.12 AbbVie
2.12.1 AbbVie Details
2.12.2 AbbVie Major Business
2.12.3 AbbVie PD-1 Antibody Drug Product and Services
2.12.4 AbbVie PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 AbbVie Recent Developments/Updates
2.13 TG Therapeutics, Inc
2.13.1 TG Therapeutics, Inc Details
2.13.2 TG Therapeutics, Inc Major Business
2.13.3 TG Therapeutics, Inc PD-1 Antibody Drug Product and Services
2.13.4 TG Therapeutics, Inc PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 TG Therapeutics, Inc Recent Developments/Updates
2.14 Beijing Yiqiao Shenzhou Technology Co., Ltd.
2.14.1 Beijing Yiqiao Shenzhou Technology Co., Ltd. Details
2.14.2 Beijing Yiqiao Shenzhou Technology Co., Ltd. Major Business
2.14.3 Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Product and Services
2.14.4 Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Beijing Yiqiao Shenzhou Technology Co., Ltd. Recent Developments/Updates
2.15 3SBio
2.15.1 3SBio Details
2.15.2 3SBio Major Business
2.15.3 3SBio PD-1 Antibody Drug Product and Services
2.15.4 3SBio PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 3SBio Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PD-1 ANTIBODY DRUG BY MANUFACTURER
3.1 Global PD-1 Antibody Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global PD-1 Antibody Drug Revenue by Manufacturer (2018-2023)
3.3 Global PD-1 Antibody Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of PD-1 Antibody Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 PD-1 Antibody Drug Manufacturer Market Share in 2022
3.4.2 Top 6 PD-1 Antibody Drug Manufacturer Market Share in 2022
3.5 PD-1 Antibody Drug Market: Overall Company Footprint Analysis
3.5.1 PD-1 Antibody Drug Market: Region Footprint
3.5.2 PD-1 Antibody Drug Market: Company Product Type Footprint
3.5.3 PD-1 Antibody Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global PD-1 Antibody Drug Market Size by Region
4.1.1 Global PD-1 Antibody Drug Sales Quantity by Region (2018-2029)
4.1.2 Global PD-1 Antibody Drug Consumption Value by Region (2018-2029)
4.1.3 Global PD-1 Antibody Drug Average Price by Region (2018-2029)
4.2 North America PD-1 Antibody Drug Consumption Value (2018-2029)
4.3 Europe PD-1 Antibody Drug Consumption Value (2018-2029)
4.4 Asia-Pacific PD-1 Antibody Drug Consumption Value (2018-2029)
4.5 South America PD-1 Antibody Drug Consumption Value (2018-2029)
4.6 Middle East and Africa PD-1 Antibody Drug Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global PD-1 Antibody Drug Sales Quantity by Type (2018-2029)
5.2 Global PD-1 Antibody Drug Consumption Value by Type (2018-2029)
5.3 Global PD-1 Antibody Drug Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global PD-1 Antibody Drug Sales Quantity by Application (2018-2029)
6.2 Global PD-1 Antibody Drug Consumption Value by Application (2018-2029)
6.3 Global PD-1 Antibody Drug Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America PD-1 Antibody Drug Sales Quantity by Type (2018-2029)
7.2 North America PD-1 Antibody Drug Sales Quantity by Application (2018-2029)
7.3 North America PD-1 Antibody Drug Market Size by Country
7.3.1 North America PD-1 Antibody Drug Sales Quantity by Country (2018-2029)
7.3.2 North America PD-1 Antibody Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe PD-1 Antibody Drug Sales Quantity by Type (2018-2029)
8.2 Europe PD-1 Antibody Drug Sales Quantity by Application (2018-2029)
8.3 Europe PD-1 Antibody Drug Market Size by Country
8.3.1 Europe PD-1 Antibody Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe PD-1 Antibody Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific PD-1 Antibody Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific PD-1 Antibody Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific PD-1 Antibody Drug Market Size by Region
9.3.1 Asia-Pacific PD-1 Antibody Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific PD-1 Antibody Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America PD-1 Antibody Drug Sales Quantity by Type (2018-2029)
10.2 South America PD-1 Antibody Drug Sales Quantity by Application (2018-2029)
10.3 South America PD-1 Antibody Drug Market Size by Country
10.3.1 South America PD-1 Antibody Drug Sales Quantity by Country (2018-2029)
10.3.2 South America PD-1 Antibody Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa PD-1 Antibody Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa PD-1 Antibody Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa PD-1 Antibody Drug Market Size by Country
11.3.1 Middle East & Africa PD-1 Antibody Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa PD-1 Antibody Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 PD-1 Antibody Drug Market Drivers
12.2 PD-1 Antibody Drug Market Restraints
12.3 PD-1 Antibody Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of PD-1 Antibody Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of PD-1 Antibody Drug
13.3 PD-1 Antibody Drug Production Process
13.4 PD-1 Antibody Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 PD-1 Antibody Drug Typical Distributors
14.3 PD-1 Antibody Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of PD-1 Antibody Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global PD-1 Antibody Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Pembrolizumab
1.3.3 Nivolumab
1.3.4 Sindilimab
1.3.5 Toripalimab
1.3.6 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global PD-1 Antibody Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global PD-1 Antibody Drug Market Size & Forecast
1.5.1 Global PD-1 Antibody Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global PD-1 Antibody Drug Sales Quantity (2018-2029)
1.5.3 Global PD-1 Antibody Drug Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis PD-1 Antibody Drug Product and Services
2.1.4 Novartis PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments/Updates
2.2 Thermo Fisher
2.2.1 Thermo Fisher Details
2.2.2 Thermo Fisher Major Business
2.2.3 Thermo Fisher PD-1 Antibody Drug Product and Services
2.2.4 Thermo Fisher PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Thermo Fisher Recent Developments/Updates
2.3 InvivoGen
2.3.1 InvivoGen Details
2.3.2 InvivoGen Major Business
2.3.3 InvivoGen PD-1 Antibody Drug Product and Services
2.3.4 InvivoGen PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 InvivoGen Recent Developments/Updates
2.4 BioVision Inc.
2.4.1 BioVision Inc. Details
2.4.2 BioVision Inc. Major Business
2.4.3 BioVision Inc. PD-1 Antibody Drug Product and Services
2.4.4 BioVision Inc. PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BioVision Inc. Recent Developments/Updates
2.5 Abcam
2.5.1 Abcam Details
2.5.2 Abcam Major Business
2.5.3 Abcam PD-1 Antibody Drug Product and Services
2.5.4 Abcam PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Abcam Recent Developments/Updates
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business
2.6.3 Bristol-Myers Squibb PD-1 Antibody Drug Product and Services
2.6.4 Bristol-Myers Squibb PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bristol-Myers Squibb Recent Developments/Updates
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck PD-1 Antibody Drug Product and Services
2.7.4 Merck PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck Recent Developments/Updates
2.8 Ono Pharmaceutical Co., Ltd
2.8.1 Ono Pharmaceutical Co., Ltd Details
2.8.2 Ono Pharmaceutical Co., Ltd Major Business
2.8.3 Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Product and Services
2.8.4 Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Ono Pharmaceutical Co., Ltd Recent Developments/Updates
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly PD-1 Antibody Drug Product and Services
2.9.4 Eli Lilly PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Eli Lilly Recent Developments/Updates
2.10 Chugai Pharmaceutical Co., Ltd
2.10.1 Chugai Pharmaceutical Co., Ltd Details
2.10.2 Chugai Pharmaceutical Co., Ltd Major Business
2.10.3 Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Product and Services
2.10.4 Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Chugai Pharmaceutical Co., Ltd Recent Developments/Updates
2.11 BeiGene
2.11.1 BeiGene Details
2.11.2 BeiGene Major Business
2.11.3 BeiGene PD-1 Antibody Drug Product and Services
2.11.4 BeiGene PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BeiGene Recent Developments/Updates
2.12 AbbVie
2.12.1 AbbVie Details
2.12.2 AbbVie Major Business
2.12.3 AbbVie PD-1 Antibody Drug Product and Services
2.12.4 AbbVie PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 AbbVie Recent Developments/Updates
2.13 TG Therapeutics, Inc
2.13.1 TG Therapeutics, Inc Details
2.13.2 TG Therapeutics, Inc Major Business
2.13.3 TG Therapeutics, Inc PD-1 Antibody Drug Product and Services
2.13.4 TG Therapeutics, Inc PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 TG Therapeutics, Inc Recent Developments/Updates
2.14 Beijing Yiqiao Shenzhou Technology Co., Ltd.
2.14.1 Beijing Yiqiao Shenzhou Technology Co., Ltd. Details
2.14.2 Beijing Yiqiao Shenzhou Technology Co., Ltd. Major Business
2.14.3 Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Product and Services
2.14.4 Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Beijing Yiqiao Shenzhou Technology Co., Ltd. Recent Developments/Updates
2.15 3SBio
2.15.1 3SBio Details
2.15.2 3SBio Major Business
2.15.3 3SBio PD-1 Antibody Drug Product and Services
2.15.4 3SBio PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 3SBio Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PD-1 ANTIBODY DRUG BY MANUFACTURER
3.1 Global PD-1 Antibody Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global PD-1 Antibody Drug Revenue by Manufacturer (2018-2023)
3.3 Global PD-1 Antibody Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of PD-1 Antibody Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 PD-1 Antibody Drug Manufacturer Market Share in 2022
3.4.2 Top 6 PD-1 Antibody Drug Manufacturer Market Share in 2022
3.5 PD-1 Antibody Drug Market: Overall Company Footprint Analysis
3.5.1 PD-1 Antibody Drug Market: Region Footprint
3.5.2 PD-1 Antibody Drug Market: Company Product Type Footprint
3.5.3 PD-1 Antibody Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global PD-1 Antibody Drug Market Size by Region
4.1.1 Global PD-1 Antibody Drug Sales Quantity by Region (2018-2029)
4.1.2 Global PD-1 Antibody Drug Consumption Value by Region (2018-2029)
4.1.3 Global PD-1 Antibody Drug Average Price by Region (2018-2029)
4.2 North America PD-1 Antibody Drug Consumption Value (2018-2029)
4.3 Europe PD-1 Antibody Drug Consumption Value (2018-2029)
4.4 Asia-Pacific PD-1 Antibody Drug Consumption Value (2018-2029)
4.5 South America PD-1 Antibody Drug Consumption Value (2018-2029)
4.6 Middle East and Africa PD-1 Antibody Drug Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global PD-1 Antibody Drug Sales Quantity by Type (2018-2029)
5.2 Global PD-1 Antibody Drug Consumption Value by Type (2018-2029)
5.3 Global PD-1 Antibody Drug Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global PD-1 Antibody Drug Sales Quantity by Application (2018-2029)
6.2 Global PD-1 Antibody Drug Consumption Value by Application (2018-2029)
6.3 Global PD-1 Antibody Drug Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America PD-1 Antibody Drug Sales Quantity by Type (2018-2029)
7.2 North America PD-1 Antibody Drug Sales Quantity by Application (2018-2029)
7.3 North America PD-1 Antibody Drug Market Size by Country
7.3.1 North America PD-1 Antibody Drug Sales Quantity by Country (2018-2029)
7.3.2 North America PD-1 Antibody Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe PD-1 Antibody Drug Sales Quantity by Type (2018-2029)
8.2 Europe PD-1 Antibody Drug Sales Quantity by Application (2018-2029)
8.3 Europe PD-1 Antibody Drug Market Size by Country
8.3.1 Europe PD-1 Antibody Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe PD-1 Antibody Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific PD-1 Antibody Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific PD-1 Antibody Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific PD-1 Antibody Drug Market Size by Region
9.3.1 Asia-Pacific PD-1 Antibody Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific PD-1 Antibody Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America PD-1 Antibody Drug Sales Quantity by Type (2018-2029)
10.2 South America PD-1 Antibody Drug Sales Quantity by Application (2018-2029)
10.3 South America PD-1 Antibody Drug Market Size by Country
10.3.1 South America PD-1 Antibody Drug Sales Quantity by Country (2018-2029)
10.3.2 South America PD-1 Antibody Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa PD-1 Antibody Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa PD-1 Antibody Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa PD-1 Antibody Drug Market Size by Country
11.3.1 Middle East & Africa PD-1 Antibody Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa PD-1 Antibody Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 PD-1 Antibody Drug Market Drivers
12.2 PD-1 Antibody Drug Market Restraints
12.3 PD-1 Antibody Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of PD-1 Antibody Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of PD-1 Antibody Drug
13.3 PD-1 Antibody Drug Production Process
13.4 PD-1 Antibody Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 PD-1 Antibody Drug Typical Distributors
14.3 PD-1 Antibody Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global PD-1 Antibody Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global PD-1 Antibody Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis PD-1 Antibody Drug Product and Services
Table 6. Novartis PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis Recent Developments/Updates
Table 8. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 9. Thermo Fisher Major Business
Table 10. Thermo Fisher PD-1 Antibody Drug Product and Services
Table 11. Thermo Fisher PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Thermo Fisher Recent Developments/Updates
Table 13. InvivoGen Basic Information, Manufacturing Base and Competitors
Table 14. InvivoGen Major Business
Table 15. InvivoGen PD-1 Antibody Drug Product and Services
Table 16. InvivoGen PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. InvivoGen Recent Developments/Updates
Table 18. BioVision Inc. Basic Information, Manufacturing Base and Competitors
Table 19. BioVision Inc. Major Business
Table 20. BioVision Inc. PD-1 Antibody Drug Product and Services
Table 21. BioVision Inc. PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. BioVision Inc. Recent Developments/Updates
Table 23. Abcam Basic Information, Manufacturing Base and Competitors
Table 24. Abcam Major Business
Table 25. Abcam PD-1 Antibody Drug Product and Services
Table 26. Abcam PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Abcam Recent Developments/Updates
Table 28. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 29. Bristol-Myers Squibb Major Business
Table 30. Bristol-Myers Squibb PD-1 Antibody Drug Product and Services
Table 31. Bristol-Myers Squibb PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bristol-Myers Squibb Recent Developments/Updates
Table 33. Merck Basic Information, Manufacturing Base and Competitors
Table 34. Merck Major Business
Table 35. Merck PD-1 Antibody Drug Product and Services
Table 36. Merck PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Merck Recent Developments/Updates
Table 38. Ono Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Ono Pharmaceutical Co., Ltd Major Business
Table 40. Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Product and Services
Table 41. Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Ono Pharmaceutical Co., Ltd Recent Developments/Updates
Table 43. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 44. Eli Lilly Major Business
Table 45. Eli Lilly PD-1 Antibody Drug Product and Services
Table 46. Eli Lilly PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Eli Lilly Recent Developments/Updates
Table 48. Chugai Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 49. Chugai Pharmaceutical Co., Ltd Major Business
Table 50. Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Product and Services
Table 51. Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Chugai Pharmaceutical Co., Ltd Recent Developments/Updates
Table 53. BeiGene Basic Information, Manufacturing Base and Competitors
Table 54. BeiGene Major Business
Table 55. BeiGene PD-1 Antibody Drug Product and Services
Table 56. BeiGene PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. BeiGene Recent Developments/Updates
Table 58. AbbVie Basic Information, Manufacturing Base and Competitors
Table 59. AbbVie Major Business
Table 60. AbbVie PD-1 Antibody Drug Product and Services
Table 61. AbbVie PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. AbbVie Recent Developments/Updates
Table 63. TG Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 64. TG Therapeutics, Inc Major Business
Table 65. TG Therapeutics, Inc PD-1 Antibody Drug Product and Services
Table 66. TG Therapeutics, Inc PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. TG Therapeutics, Inc Recent Developments/Updates
Table 68. Beijing Yiqiao Shenzhou Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 69. Beijing Yiqiao Shenzhou Technology Co., Ltd. Major Business
Table 70. Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Product and Services
Table 71. Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Beijing Yiqiao Shenzhou Technology Co., Ltd. Recent Developments/Updates
Table 73. 3SBio Basic Information, Manufacturing Base and Competitors
Table 74. 3SBio Major Business
Table 75. 3SBio PD-1 Antibody Drug Product and Services
Table 76. 3SBio PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. 3SBio Recent Developments/Updates
Table 78. Global PD-1 Antibody Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global PD-1 Antibody Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global PD-1 Antibody Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in PD-1 Antibody Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and PD-1 Antibody Drug Production Site of Key Manufacturer
Table 83. PD-1 Antibody Drug Market: Company Product Type Footprint
Table 84. PD-1 Antibody Drug Market: Company Product Application Footprint
Table 85. PD-1 Antibody Drug New Market Entrants and Barriers to Market Entry
Table 86. PD-1 Antibody Drug Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global PD-1 Antibody Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global PD-1 Antibody Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global PD-1 Antibody Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global PD-1 Antibody Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global PD-1 Antibody Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global PD-1 Antibody Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global PD-1 Antibody Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global PD-1 Antibody Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global PD-1 Antibody Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global PD-1 Antibody Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global PD-1 Antibody Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global PD-1 Antibody Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global PD-1 Antibody Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global PD-1 Antibody Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global PD-1 Antibody Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global PD-1 Antibody Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global PD-1 Antibody Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global PD-1 Antibody Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America PD-1 Antibody Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America PD-1 Antibody Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America PD-1 Antibody Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America PD-1 Antibody Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America PD-1 Antibody Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America PD-1 Antibody Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America PD-1 Antibody Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America PD-1 Antibody Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe PD-1 Antibody Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe PD-1 Antibody Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe PD-1 Antibody Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe PD-1 Antibody Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe PD-1 Antibody Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe PD-1 Antibody Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe PD-1 Antibody Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe PD-1 Antibody Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific PD-1 Antibody Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific PD-1 Antibody Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific PD-1 Antibody Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific PD-1 Antibody Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific PD-1 Antibody Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific PD-1 Antibody Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific PD-1 Antibody Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific PD-1 Antibody Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America PD-1 Antibody Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America PD-1 Antibody Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America PD-1 Antibody Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America PD-1 Antibody Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America PD-1 Antibody Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America PD-1 Antibody Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America PD-1 Antibody Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America PD-1 Antibody Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa PD-1 Antibody Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa PD-1 Antibody Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa PD-1 Antibody Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa PD-1 Antibody Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa PD-1 Antibody Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa PD-1 Antibody Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa PD-1 Antibody Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa PD-1 Antibody Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 145. PD-1 Antibody Drug Raw Material
Table 146. Key Manufacturers of PD-1 Antibody Drug Raw Materials
Table 147. PD-1 Antibody Drug Typical Distributors
Table 148. PD-1 Antibody Drug Typical Customers
List of Figures
Figure 1. PD-1 Antibody Drug Picture
Figure 2. Global PD-1 Antibody Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global PD-1 Antibody Drug Consumption Value Market Share by Type in 2022
Figure 4. Pembrolizumab Examples
Figure 5. Nivolumab Examples
Figure 6. Sindilimab Examples
Figure 7. Toripalimab Examples
Figure 8. Other Examples
Figure 9. Global PD-1 Antibody Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global PD-1 Antibody Drug Consumption Value Market Share by Application in 2022
Figure 11. Hospital Examples
Figure 12. Clinic Examples
Figure 13. Other Examples
Figure 14. Global PD-1 Antibody Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global PD-1 Antibody Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global PD-1 Antibody Drug Sales Quantity (2018-2029) & (K Units)
Figure 17. Global PD-1 Antibody Drug Average Price (2018-2029) & (US$/Unit)
Figure 18. Global PD-1 Antibody Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global PD-1 Antibody Drug Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of PD-1 Antibody Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 PD-1 Antibody Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 PD-1 Antibody Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global PD-1 Antibody Drug Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global PD-1 Antibody Drug Consumption Value Market Share by Region (2018-2029)
Figure 25. North America PD-1 Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe PD-1 Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific PD-1 Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 28. South America PD-1 Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa PD-1 Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 30. Global PD-1 Antibody Drug Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global PD-1 Antibody Drug Consumption Value Market Share by Type (2018-2029)
Figure 32. Global PD-1 Antibody Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global PD-1 Antibody Drug Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global PD-1 Antibody Drug Consumption Value Market Share by Application (2018-2029)
Figure 35. Global PD-1 Antibody Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America PD-1 Antibody Drug Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America PD-1 Antibody Drug Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America PD-1 Antibody Drug Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America PD-1 Antibody Drug Consumption Value Market Share by Country (2018-2029)
Figure 40. United States PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe PD-1 Antibody Drug Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe PD-1 Antibody Drug Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe PD-1 Antibody Drug Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe PD-1 Antibody Drug Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific PD-1 Antibody Drug Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific PD-1 Antibody Drug Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific PD-1 Antibody Drug Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific PD-1 Antibody Drug Consumption Value Market Share by Region (2018-2029)
Figure 56. China PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America PD-1 Antibody Drug Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America PD-1 Antibody Drug Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America PD-1 Antibody Drug Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America PD-1 Antibody Drug Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa PD-1 Antibody Drug Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa PD-1 Antibody Drug Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa PD-1 Antibody Drug Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa PD-1 Antibody Drug Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. PD-1 Antibody Drug Market Drivers
Figure 77. PD-1 Antibody Drug Market Restraints
Figure 78. PD-1 Antibody Drug Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of PD-1 Antibody Drug in 2022
Figure 81. Manufacturing Process Analysis of PD-1 Antibody Drug
Figure 82. PD-1 Antibody Drug Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Table 1. Global PD-1 Antibody Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global PD-1 Antibody Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis PD-1 Antibody Drug Product and Services
Table 6. Novartis PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis Recent Developments/Updates
Table 8. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 9. Thermo Fisher Major Business
Table 10. Thermo Fisher PD-1 Antibody Drug Product and Services
Table 11. Thermo Fisher PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Thermo Fisher Recent Developments/Updates
Table 13. InvivoGen Basic Information, Manufacturing Base and Competitors
Table 14. InvivoGen Major Business
Table 15. InvivoGen PD-1 Antibody Drug Product and Services
Table 16. InvivoGen PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. InvivoGen Recent Developments/Updates
Table 18. BioVision Inc. Basic Information, Manufacturing Base and Competitors
Table 19. BioVision Inc. Major Business
Table 20. BioVision Inc. PD-1 Antibody Drug Product and Services
Table 21. BioVision Inc. PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. BioVision Inc. Recent Developments/Updates
Table 23. Abcam Basic Information, Manufacturing Base and Competitors
Table 24. Abcam Major Business
Table 25. Abcam PD-1 Antibody Drug Product and Services
Table 26. Abcam PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Abcam Recent Developments/Updates
Table 28. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 29. Bristol-Myers Squibb Major Business
Table 30. Bristol-Myers Squibb PD-1 Antibody Drug Product and Services
Table 31. Bristol-Myers Squibb PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Bristol-Myers Squibb Recent Developments/Updates
Table 33. Merck Basic Information, Manufacturing Base and Competitors
Table 34. Merck Major Business
Table 35. Merck PD-1 Antibody Drug Product and Services
Table 36. Merck PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Merck Recent Developments/Updates
Table 38. Ono Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 39. Ono Pharmaceutical Co., Ltd Major Business
Table 40. Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Product and Services
Table 41. Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Ono Pharmaceutical Co., Ltd Recent Developments/Updates
Table 43. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 44. Eli Lilly Major Business
Table 45. Eli Lilly PD-1 Antibody Drug Product and Services
Table 46. Eli Lilly PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Eli Lilly Recent Developments/Updates
Table 48. Chugai Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 49. Chugai Pharmaceutical Co., Ltd Major Business
Table 50. Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Product and Services
Table 51. Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Chugai Pharmaceutical Co., Ltd Recent Developments/Updates
Table 53. BeiGene Basic Information, Manufacturing Base and Competitors
Table 54. BeiGene Major Business
Table 55. BeiGene PD-1 Antibody Drug Product and Services
Table 56. BeiGene PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. BeiGene Recent Developments/Updates
Table 58. AbbVie Basic Information, Manufacturing Base and Competitors
Table 59. AbbVie Major Business
Table 60. AbbVie PD-1 Antibody Drug Product and Services
Table 61. AbbVie PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. AbbVie Recent Developments/Updates
Table 63. TG Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 64. TG Therapeutics, Inc Major Business
Table 65. TG Therapeutics, Inc PD-1 Antibody Drug Product and Services
Table 66. TG Therapeutics, Inc PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. TG Therapeutics, Inc Recent Developments/Updates
Table 68. Beijing Yiqiao Shenzhou Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 69. Beijing Yiqiao Shenzhou Technology Co., Ltd. Major Business
Table 70. Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Product and Services
Table 71. Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Beijing Yiqiao Shenzhou Technology Co., Ltd. Recent Developments/Updates
Table 73. 3SBio Basic Information, Manufacturing Base and Competitors
Table 74. 3SBio Major Business
Table 75. 3SBio PD-1 Antibody Drug Product and Services
Table 76. 3SBio PD-1 Antibody Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. 3SBio Recent Developments/Updates
Table 78. Global PD-1 Antibody Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global PD-1 Antibody Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global PD-1 Antibody Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in PD-1 Antibody Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and PD-1 Antibody Drug Production Site of Key Manufacturer
Table 83. PD-1 Antibody Drug Market: Company Product Type Footprint
Table 84. PD-1 Antibody Drug Market: Company Product Application Footprint
Table 85. PD-1 Antibody Drug New Market Entrants and Barriers to Market Entry
Table 86. PD-1 Antibody Drug Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global PD-1 Antibody Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global PD-1 Antibody Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global PD-1 Antibody Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global PD-1 Antibody Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global PD-1 Antibody Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global PD-1 Antibody Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global PD-1 Antibody Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global PD-1 Antibody Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global PD-1 Antibody Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global PD-1 Antibody Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global PD-1 Antibody Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global PD-1 Antibody Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global PD-1 Antibody Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global PD-1 Antibody Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global PD-1 Antibody Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global PD-1 Antibody Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global PD-1 Antibody Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global PD-1 Antibody Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America PD-1 Antibody Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America PD-1 Antibody Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America PD-1 Antibody Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America PD-1 Antibody Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America PD-1 Antibody Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America PD-1 Antibody Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America PD-1 Antibody Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America PD-1 Antibody Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe PD-1 Antibody Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe PD-1 Antibody Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe PD-1 Antibody Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe PD-1 Antibody Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe PD-1 Antibody Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe PD-1 Antibody Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe PD-1 Antibody Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe PD-1 Antibody Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific PD-1 Antibody Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific PD-1 Antibody Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific PD-1 Antibody Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific PD-1 Antibody Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific PD-1 Antibody Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific PD-1 Antibody Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific PD-1 Antibody Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific PD-1 Antibody Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America PD-1 Antibody Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America PD-1 Antibody Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America PD-1 Antibody Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America PD-1 Antibody Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America PD-1 Antibody Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America PD-1 Antibody Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America PD-1 Antibody Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America PD-1 Antibody Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa PD-1 Antibody Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa PD-1 Antibody Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa PD-1 Antibody Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa PD-1 Antibody Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa PD-1 Antibody Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa PD-1 Antibody Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa PD-1 Antibody Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa PD-1 Antibody Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 145. PD-1 Antibody Drug Raw Material
Table 146. Key Manufacturers of PD-1 Antibody Drug Raw Materials
Table 147. PD-1 Antibody Drug Typical Distributors
Table 148. PD-1 Antibody Drug Typical Customers
List of Figures
Figure 1. PD-1 Antibody Drug Picture
Figure 2. Global PD-1 Antibody Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global PD-1 Antibody Drug Consumption Value Market Share by Type in 2022
Figure 4. Pembrolizumab Examples
Figure 5. Nivolumab Examples
Figure 6. Sindilimab Examples
Figure 7. Toripalimab Examples
Figure 8. Other Examples
Figure 9. Global PD-1 Antibody Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global PD-1 Antibody Drug Consumption Value Market Share by Application in 2022
Figure 11. Hospital Examples
Figure 12. Clinic Examples
Figure 13. Other Examples
Figure 14. Global PD-1 Antibody Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global PD-1 Antibody Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global PD-1 Antibody Drug Sales Quantity (2018-2029) & (K Units)
Figure 17. Global PD-1 Antibody Drug Average Price (2018-2029) & (US$/Unit)
Figure 18. Global PD-1 Antibody Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global PD-1 Antibody Drug Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of PD-1 Antibody Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 PD-1 Antibody Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 PD-1 Antibody Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global PD-1 Antibody Drug Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global PD-1 Antibody Drug Consumption Value Market Share by Region (2018-2029)
Figure 25. North America PD-1 Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe PD-1 Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific PD-1 Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 28. South America PD-1 Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa PD-1 Antibody Drug Consumption Value (2018-2029) & (USD Million)
Figure 30. Global PD-1 Antibody Drug Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global PD-1 Antibody Drug Consumption Value Market Share by Type (2018-2029)
Figure 32. Global PD-1 Antibody Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global PD-1 Antibody Drug Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global PD-1 Antibody Drug Consumption Value Market Share by Application (2018-2029)
Figure 35. Global PD-1 Antibody Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America PD-1 Antibody Drug Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America PD-1 Antibody Drug Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America PD-1 Antibody Drug Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America PD-1 Antibody Drug Consumption Value Market Share by Country (2018-2029)
Figure 40. United States PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe PD-1 Antibody Drug Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe PD-1 Antibody Drug Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe PD-1 Antibody Drug Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe PD-1 Antibody Drug Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific PD-1 Antibody Drug Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific PD-1 Antibody Drug Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific PD-1 Antibody Drug Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific PD-1 Antibody Drug Consumption Value Market Share by Region (2018-2029)
Figure 56. China PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America PD-1 Antibody Drug Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America PD-1 Antibody Drug Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America PD-1 Antibody Drug Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America PD-1 Antibody Drug Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa PD-1 Antibody Drug Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa PD-1 Antibody Drug Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa PD-1 Antibody Drug Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa PD-1 Antibody Drug Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa PD-1 Antibody Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. PD-1 Antibody Drug Market Drivers
Figure 77. PD-1 Antibody Drug Market Restraints
Figure 78. PD-1 Antibody Drug Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of PD-1 Antibody Drug in 2022
Figure 81. Manufacturing Process Analysis of PD-1 Antibody Drug
Figure 82. PD-1 Antibody Drug Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
